Drug Delivery to the Brain

Feb 15–18, 2027 | Rimrock Banff, Emblems Collection, Banff, AB, Canada
Scientific Organizers: Joy Yu Zuchero and Peter Tessier

  Livestream
  In Person
  On Demand
 Add to Calendar
×

-

Feb 15–18, 2027 | Rimrock Banff, Emblems Collection, Banff, AB, Canada

Scientific Organizers: Joy Yu Zuchero and Peter Tessier

Supported by:
Important Deadlines
Early Registration Deadline: December 15, 2026
Scholarship Deadline: November 3, 2026
Short Talk Abstract Deadline: November 3, 2026
Poster Abstract Deadline: January 22, 2027
Meeting Summary

About This Meeting:


The blood-brain barrier remains a major challenge for the development and implementation of safe and effective therapeutics for neurological diseases. Recent advances in the brain delivery field have garnered significant attention, including important advances both preclinically and clinically. These promising results have accelerated research in the CNS drug delivery field. This conference aims to identify challenges and gaps that may hinder successful clinical translatability of different CNS drug delivery modalities. 

This Keystone Symposium on Drug Delivery to the Brain will focus on sharing the latest scientific and technological advances in this burgeoning area from both academia and industry. The meeting will showcase the latest research and progress in established receptor-mediated transport targets across delivery modalities, new RMT targets that can be exploited for delivery to further provide optionality, platform engineering for additional properties to enhance both delivery and functionality, alternative modes of drug delivery, successes and challenges in preclinical in vivo models, and latest clinical data utilizing CNS delivery platforms along with a focus on lessons learned. 

This meeting will bring together scientists and trainees from across academia and industry in the fields of basic neuroscience, bioengineering, drug discovery, and clinical science. By bridging across many disciplines that are normally discussed at separate conferences, the meeting fosters the cross-disciplinary collaboration essential for advancing CNS therapeutics. 

This meeting is unique in its ability to convene sectors that can bring unique perspectives to how we continue to innovate in the field of CNS drug delivery, positioning itself as a pivotal forum to maximize clinical success and accelerate progress towards meeting major unmet medical needs for the treatment of neurological diseases.


Check out the speaker highlights in the video below:


Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates